Breaking News

TAG: insulin copays

The Good, the Bad and the Stupid 8

The West Virginia Legislature has finally wrapped up its regular legislative session. As we expected, the last few days were a marathon of chaos, with many bills just barely passing before deadline and several unexpectedly left behind in the dust.   The Editorial Board had more than ...

The point where ethics and profits intersect

While the West Virginia Legislature debated making insulin more affordable, one pharmaceutical company surprisingly stepped up. On March 1, Eli Lilly announced it would limit monthly patient out-of-pocket costs to $35 or less for its most common insulins: its non-branded insulin starting ...

The Good, the Bad and the Stupid 6

Good: SB 577 is the resurrected insulin copay cap. Last year’s iteration, HB 4252, passed both chambers, but the House didn’t concur with the Senate’s changes before the session ended, so the bill died. SB 577 might actually be improved: It limits the copay for insulin (even if the ...

  • 1
  • 2